Laurus Labs Ltd

540222

Overview

    • Equity Style Box

      Mid Blend

    • Sector

      Healthcare

    • Industry

      Drug Manufacturers - Specialty & Generic

    • Day Range

      610.35 – 619.45

    • Year Range

      386.85 – 646.25

    • Market Cap

      331.4785 Bil

    • Volume / Avg

      30.6 k / 113.5 k

    • Price / Sales

      6.34

    • Price / Book

      8.02

    • Price / Earnings

      165.69

    • Forward Div Yield

      0.13%

    • Trailing Div Yield

      0.13%

Login To Show Full Chart

Summary

Fair Value Assessment
Overvalued (35% Premium)
Fair ValueQ454.28UncertaintyHigh
Close Price614.70Mar 25, 2025
Market Closed
₹ 614.70
Price Down by — | — %
Trading Information Business Description
Previous Close
614.70
Day Range
610.35 – 619.45
Year Range
386.85 – 646.25
Bid / Ask
—
Market Cap
331.5 Bil
Volume / Average
30.6 k / 113.5 k
Beta (5-Year)
1.50
Shares Outstanding
539.25 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.
Contact
Road No. 7, Banjara Hills 2nd Floor, Serene Chambers, Hyderabad, TG 500034
T +91 4039804333
www.lauruslabs.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
6,735
As of Mar 31, 2024

Key Metrics

Income Statement (in Bil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
52.34 50.02 60.14 48.89 47.23 27.59
Revenue Growth %
5.62% -16.83% 23.03% 3.50% 71.22% 23.15%
Gross Profit
27.50 25.03 31.74 26.40 25.26 13.15
Gross Profit Margin %
52.54% 50.04% 52.77% 54.01% 53.48% 47.65%
Operating Income
4.56 3.95 12.93 11.72 13.46 3.79
Operating Margin %
8.72% 7.89% 21.50% 23.98% 28.51% 13.75%
EBIT
4.73 4.03 12.27 11.58 13.56 3.66
EBIT Margin %
9.03% 8.05% 20.41% 23.69% 28.71% 13.27%
EBITDA
8.94 7.87 15.51 14.09 15.61 5.53
EBITDA Margin %
17.09% 15.74% 25.79% 28.83% 33.05% 20.06%
Net Income
2.00 1.61 7.90 8.28 9.84 2.55
Net Profit Margin %
3.83% 3.24% 13.19% 17.02% 20.83% 9.25%
Basic EPS
3.71 2.98 14.69 15.42 18.36 4.79
Diluted EPS
3.71 2.97 14.64 15.35 18.28 4.79
Normalized EPS
3.81 3.03 14.88 15.54 18.08 5.96
Total Dividends per Share
0.80 1.60 2.00 1.60 1.40 0.60
Balance Sheet (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
87.29 83.87 76.60 69.68 57.51 37.50
Total Liabilities
45.85 42.71 36.12 36.09 31.50 19.81
Total Debt
27.89 25.77 20.15 17.77 14.82 10.79
Total Equity
41.44 41.16 40.49 33.59 26.01 17.70
Cash And Cash Equivalents
0.43 1.39 0.46 0.75 0.48 0.02
Working Capital
6.60 7.23 10.29 6.64 6.18 1.20
Shares Outstanding (Bil)
0.54 0.54 0.54 — — —
Book Value Per Share
— 75.88 74.73 62.19 48.32 33.02
Total Debt To Equity
0.67 0.63 0.50 0.53 0.57 0.61
Cash Flow Statement (in Bil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
2.49 6.66 9.94 9.11 7.33 3.47
Cash From Investing Activities
-6.72 -8.22 -9.96 -9.14 -9.41 -2.21
Cash From Financing Activities
3.96 2.50 -0.27 0.30 2.55 -1.28
Capital Expenditures
— 6.78 9.90 8.77 6.89 2.22
Free Cash Flow
— -1.58 1.79 2.91 5.80 2.39
Change in Cash
-0.26 0.93 -0.29 0.27 0.47 -0.01

Profile

Name (Age)
5-Year Trend
2021
2022
2023
2024
2025
Satyanarayana Chava (—) Director and Chief Executive Officer — — — — — —
Venkata Ravi Kumar Vantaram (59) Director and Chief Financial Officer — — — — — —
Krishna Chaitanya (34) Executive Director, President and Head of Synthesis Business unit — — — — — —
Total Compensation for all Key Executives — — — — — —
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

Name
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Change Amount
Change %
Date
Capital Group New Geography Equity Comp 6.50 0.40 35,030,909
—
—
Dec 31, 2024
American Funds New World A 6.50 0.40 35,030,909
—
—
Dec 31, 2024
American Funds SMALLCAP World A 4.25 0.22 22,935,270
862,512
3.91%
Dec 31, 2024
GS India Equity I Inc USD 1.18 0.83 6,376,522
249,915
4.08%
Jan 31, 2025
Kotak India Midcap Diversified Fund Not Rated 1.16 1.19 6,250,000
-250,000
3.85%
Feb 28, 2025
Total (for Top 5) 19.59 105,623,610
862,427
More Ownership Data

STOCKS
MUTUAL FUNDS
ADITYABIRLAAXISBajajBANDHANBARODABNPBOICANARADSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top